Equibles does not estimate personal net worth.
Birgit Girshick is recorded as Board Member at Charles River Laboratories International, Inc. (CRL) since May 5, 2026, COO at Charles River Laboratories International, Inc. (CRL) since November 11, 2021 and CEO at Charles River Laboratories International, Inc. (CRL). Charles River Laboratories International, Inc. reported in an 8-K filed May 11, 2026 that Birgit Girshick was appointed director, effective May 5, 2026. Charles River Laboratories International, Inc. reported in an 8-K filed January 9, 2026 that Birgit Girshick was appointed Chief Executive Officer, effective May 5, 2026. The proxy statement of Charles River Laboratories International, Inc. reports total compensation of $5,056,475 for Birgit Girshick in fiscal 2024, including a base salary of $742,485. Disclosed compensation is on record for 7 fiscal years. Birgit Girshick has spoken on 2 earnings calls and 2 other investor events across 1 company, most recently for Charles River Laboratories International, Inc. on August 5, 2026. Charles River Laboratories International, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Charles River Laboratories International, Inc. includes Abraham Ceesay (CEO and Board Member), Craig B. Thompson (CEO and Board Member), James C. Foster (CEO and Board Member) and 7 others.
“The following twelve (12) directors were elected to serve until our 2027 Annual Meeting of Shareholders and received the number of votes listed opposite each of their names below:”
“Mr. James C. Foster, our current Chairman of the Board, President and Chief Executive Officer, intends to step down as Chief Executive Officer and Chairman of the Board, and Ms. Birgit Girshick, our Chief Operating Officer, will be appointed as our Chief Executive Officer, each effective as of May 5, 2026 (the "Transition Date").”
“Today, I would like to discuss the progress that we made during the second quarter, both financially and on our refreshed strategic framework, Pathway to Purpose.”
“Also really excited taking on the role of CEO. It's a huge privilege for me, and particularly following Jim after all his years. So, yeah, I just wanted to update a little bit on what my focus areas are.”
“I'm really excited to be here, and thanks for joining us for this presentation today. During the presentation today, I will focus on three things. How we are re-strengthening the core, how we re-accelerate growth, and how this will translate into margin expansion and durable shareholder value.”
“First, I want to sincerely thank you, Jim, for the tremendous mentorship and close partnership you have provided over the years to prepare me for this incredible opportunity and also for your significant contributions to build the company into the industry leader that we are today.”
2026-05-05–present
2021-11-11–present
Diagnostics & Research · Healthcare
CEO, Board Member, COO
2021-11-11–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Charles River Laboratories International, Inc. (CRL) | Corporate Executive Vice President, Chief Operating Officer | $742,485 | $5,056,475 |
| 2023 | Charles River Laboratories International, Inc. (CRL) | Corporate Executive Vice President, Chief Operating Officer | $704,811 | $4,989,672 |
| 2022 | Charles River Laboratories International, Inc. (CRL) | Corporate Executive Vice President, Chief Operating Officer | $650,000 | $4,165,529 |
| 2021 | Charles River Laboratories International, Inc. (CRL) | Corporate Executive Vice President, Chief Operating Officer | $502,351 | $3,196,674 |
| 2020 | Charles River Laboratories International, Inc. (CRL) | Corporate Executive Vice President, Chief Operating Officer | $475,329 | $2,646,443 |
| 2019 | Charles River Laboratories International, Inc. (CRL) | Corporate Executive Vice President, Chief Operating Officer | $438,526 | $2,988,001 |
| 2018 | Charles River Laboratories International, Inc. (CRL) | Corporate Executive Vice President, Discovery and | $397,040 | $2,523,356 |
